Cargando…
The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer
BACKGROUND: The effects of adjuvant chemotherapy in patients with stage II colorectal cancer (CRC) has been in controversy for a long time. Our study aimed to find an effective inflammatory marker to predict the effects of chemotherapy. METHODS: Seven hundred eight stage II CRC patients in our insti...
Autores principales: | Fu, Yu, Chen, Xiaowan, Song, Yongxi, Huang, Xuanzhang, Chen, Quan, Lv, Xinger, Gao, Peng, Wang, Zhenning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268489/ https://www.ncbi.nlm.nih.gov/pubmed/34238262 http://dx.doi.org/10.1186/s12885-021-08521-0 |
Ejemplares similares
-
Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
por: Chen, Quan, et al.
Publicado: (2020) -
Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer
por: Lu, Chong, et al.
Publicado: (2017) -
tRFTars: predicting the targets of tRNA-derived fragments
por: Xiao, Qiong, et al.
Publicado: (2021) -
Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
por: Sun, Jingxu, et al.
Publicado: (2016) -
Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis
por: Huang, Xuanzhang, et al.
Publicado: (2014)